Cargando…
CYTOMEGALOVIRUS COLITIS POST IL-6 INHIBITOR USE IN COVID-19 INFECTION
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American College of Chest Physicians. Published by Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7548634/ http://dx.doi.org/10.1016/j.chest.2020.08.719 |
_version_ | 1783592659539984384 |
---|---|
author | Jiwa, Nasheena Lorick, Kiran Mutneja, Rahul |
author_facet | Jiwa, Nasheena Lorick, Kiran Mutneja, Rahul |
author_sort | Jiwa, Nasheena |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7548634 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | American College of Chest Physicians. Published by Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-75486342020-10-13 CYTOMEGALOVIRUS COLITIS POST IL-6 INHIBITOR USE IN COVID-19 INFECTION Jiwa, Nasheena Lorick, Kiran Mutneja, Rahul Chest Critical Care American College of Chest Physicians. Published by Elsevier Inc. 2020-10 2020-10-12 /pmc/articles/PMC7548634/ http://dx.doi.org/10.1016/j.chest.2020.08.719 Text en Copyright © 2020 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Critical Care Jiwa, Nasheena Lorick, Kiran Mutneja, Rahul CYTOMEGALOVIRUS COLITIS POST IL-6 INHIBITOR USE IN COVID-19 INFECTION |
title | CYTOMEGALOVIRUS COLITIS POST IL-6 INHIBITOR USE IN COVID-19 INFECTION |
title_full | CYTOMEGALOVIRUS COLITIS POST IL-6 INHIBITOR USE IN COVID-19 INFECTION |
title_fullStr | CYTOMEGALOVIRUS COLITIS POST IL-6 INHIBITOR USE IN COVID-19 INFECTION |
title_full_unstemmed | CYTOMEGALOVIRUS COLITIS POST IL-6 INHIBITOR USE IN COVID-19 INFECTION |
title_short | CYTOMEGALOVIRUS COLITIS POST IL-6 INHIBITOR USE IN COVID-19 INFECTION |
title_sort | cytomegalovirus colitis post il-6 inhibitor use in covid-19 infection |
topic | Critical Care |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7548634/ http://dx.doi.org/10.1016/j.chest.2020.08.719 |
work_keys_str_mv | AT jiwanasheena cytomegaloviruscolitispostil6inhibitoruseincovid19infection AT lorickkiran cytomegaloviruscolitispostil6inhibitoruseincovid19infection AT mutnejarahul cytomegaloviruscolitispostil6inhibitoruseincovid19infection |